Long Term Administration of Inhaled Dry Powder Mannitol In Cystic Fibrosis - A Safety and Efficacy Study
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Brett Charlton, MBBS
Pharmaxis Ltd Australia
Study Director - Dr Diana Bilton
Papworth Hospital NHS Foundation Trust
Principal Investigator - Dr Philip Robinson
Royal Children's Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
29 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Childrens Hospital at Westmead
Sydney, New South Wales, Australia
- Sydney Childrens Hospital
Sydney, New South Wales, Australia
- Royal Brisbane Children'S Hospital
Brisbane, Queensland, Australia
- the Prince Charles Hospital
Brisbane, Queensland, Australia
- Royal Adelaide Hospital
Adelaide, South Australia, Australia
- Royal Childrens Hospital
Melbourne, Victoria, Australia
- Beaumont Hospital
Dublin, Ireland
- National Children'S Hospital
Dublin, Ireland
- Our Lady'S Hospital for Sick Children
Dublin, Ireland
- St Vincent'S University Hospital
Dublin, Ireland
- Alder Hey Children'S Hospital
West Derby, Liverpool, United Kingdom
- Belfast City Hospital
Belfast, Northern Ireland, United Kingdom
- Children'S Hospital for Wales
Cardiff, Wales, United Kingdom
- Llandough Hospital
Cardiff, Wales, United Kingdom
- Birmingham Children'S Hospital
Birmingham, United Kingdom
- Birmingham Heartlands Hospital
Birmingham, United Kingdom
- Bristol Royal Hospital for Children
Bristol, United Kingdom
- Bristol Royal Infirmary
Bristol, United Kingdom
- Addenbrooke'S Hospital
Cambridge, United Kingdom
- Papworth Hospital
Cambridge, United Kingdom
- Seacroft Hospital
Leeds, United Kingdom
- Cardiothoracic Centre
Liverpool, United Kingdom
- the London Chest Hospital
London, United Kingdom
- Freeman Hospital
Newcastle, United Kingdom
- Norfolk and Norwich University Hospital
Norwich, United Kingdom
- Nottingham City Hospital
Nottingham, United Kingdom
- Northern General Hospital
Sheffield, United Kingdom
- Sheffield Children'S Hospital
Sheffield, United Kingdom
- Southampton General Hospital
Southampton, United Kingdom
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2007
- Primary completion
- 31 May 2010
- Completion
- 31 May 2010
- Last update posted
- 25 Jun 2010
- Registered enrollment
- 340
- Registry id
- NCT00446680
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.